Corteva (CTVA) Financial History
Former S&P 500 member. Corteva left the index on 2026-10-01 after the spin-off of Vylor and moved to the S&P MidCap 400.
Review Corteva annual and quarterly financial results, key ratios, insider transactions and SEC filing history in one chronological view. Data available from FY2018 through FY2025.
Financials
8 fiscal years, FY2018 to FY2025
Insider trades
340 trades
Risk factor changes
15 changes in the latest 10-K
Filings
Annual and quarterly reports
Compare
Side by side with another company
Corteva Financial Statements
History since FY2018. Annual, in US dollars. Source: 10-K XBRL data.
Corteva Revenue and Growth
Compare reported revenue and year-over-year revenue growth across available fiscal years.
Corteva Income Statements
Review revenue, gross profit, operating income, net income and earnings per share.
Corteva Balance Sheets
Review reported debt and book-value-based ratios where company data is available.
Corteva Cash Flow Statements
Compare reported free cash flow across the available fiscal history.
Corteva Financial Ratios
Compare net margin, price-to-earnings and price-to-book ratios by fiscal year.
| Fiscal year | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY20226 new risk factorsInsiders net sold $3.9M | FY20235 new risk factorsInsiders net bought $2.8M | FY20246 new risk factorsInsiders net sold $7.2M | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ••••• | ••••• | ••••• | $15.7B | $17.5B | $17.2B | $16.9B | $17.4B |
| Revenue growth | ••••• | ••••• | ••••• | — | +11.5% | -1.3% | -1.8% | +2.9% |
| Gross profit | ••••• | ••••• | ••••• | $6.4B | $7.0B | $7.3B | $7.4B | $8.2B |
| Operating income | ••••• | ••••• | ••••• | — | — | — | — | — |
| Net income | ••••• | ••••• | ••••• | $1.8B | $1.1B | $0.7B | $0.9B | $1.1B |
| Debt | ••••• | ••••• | ••••• | $1.1B | $1.3B | $2.5B | $2.7B | $2.6B |
| Free cash flow | ••••• | ••••• | ••••• | $2.2B | $0.3B | $1.2B | $1.5B | $2.8B |
| Net margin | ••••• | ••••• | ••••• | 11.2% | 6.6% | 4.3% | 5.4% | 6.3% |
| EPS (diluted) | ••••• | ••••• | ••••• | $2.37 | $1.58 | $1.03 | $1.30 | $1.60 |
| P/E ratio | ••••• | ••••• | ••••• | 20.0× | 37.2× | 46.6× | 43.8× | 41.9× |
| P/B ratio | ••••• | ••••• | ••••• | 1.4× | 1.7× | 1.3× | 1.6× | 1.9× |
Daily closing prices, aggregated by calendar year.
| Year | 2019 🔒 | 2020 🔒 | 2021 🔒 | 2022 | 2023 | 2024 | 2025 | 2026 (YTD) |
|---|---|---|---|---|---|---|---|---|
| Open | ••••• | ••••• | ••••• | $47.24 | $58.67 | $47.88 | $57.15 | $67.11 |
| Close | ••••• | ••••• | ••••• | $58.77 | $47.95 | $56.96 | $67.06 | $12.03 |
| High | ••••• | ••••• | ••••• | $68.42 | $65.21 | $64.20 | $77.41 | $90.97 |
| Low | ••••• | ••••• | ••••• | $43.75 | $43.22 | $44.08 | $53.40 | $11.24 |
| Annual return | ••••• | ••••• | ••••• | +24.3% | -18.4% | +18.8% | +17.7% | -82.1% |
Corteva Insider Transactions
From Form 4 filings. Showing the latest 5 of 340 trades.
| Traded | Filed | Insider | Type | Shares | Value | % of holdings |
|---|---|---|---|---|---|---|
| 2026-10-30 | 2026-11-03 | Christopher Policinski Director | Grant or award | 2,792.096 | $32K | — |
| 2026-10-30 | 2026-11-03 | Nayaki Nayyar Director | Grant or award | 2,792.096 | $32K | — |
| 2026-10-30 | 2026-11-03 | Janet Plaut Giesselman Director | Grant or award | 665.808 | $7,750 | — |
| 2026-10-01 | 2026-10-05 | Brian Titus See Remarks | Other (5 trades) | 71,224.132 | — | — |
| 2026-10-01 | 2026-10-05 | Luther Kissam IV CEO | Other | 127,949 | — | — |
Corteva Risk Factor Changes
Latest 10-K compared with the year before. 15 changes found.
The company, pursuant to the respective Separation Agreements, is entitled to cost sharing and indemnification from Chemours, Dow and DuPont, as applicable, for certain litigation, environmental, workers’ compensation…
Corteva faces risks arising from various unasserted and asserted litigation matters arising out of the normal course of its current and former business operations, including intellectual property, commercial, product…
Corteva accrues for environmental matters when it is probable that a liability has been incurred and the amount can be reasonably estimated.
Corteva expects to continue to incur environmental operating costs since it will operate global manufacturing, product handling and distribution facilities that are subject to a broad array of environmental laws and r…
As a result of Corteva’s operations, including past operations and those related to divested businesses and discontinued operations of EIDP, Corteva incurs environmental operating costs for pollution abatement activit…
Corteva’s business, results of operations and financial condition could be adversely affected by environmental, litigation and other commitments and contingencies.
The company is dependent to a certain extent on DuPont and Dow to maintain and enforce certain of the intellectual property licensed under the Intellectual Property Cross-License Agreements.
Restrictions under the intellectual property cross-license agreements limit Corteva’s ability to develop and commercialize certain products and services and/or prosecute, maintain and enforce certain intellectual prop…
Corteva undertakes significant efforts to counteract the threats associated with counterfeit products, including, among other things, working with regulatory authorities and multinational coalitions to combat the coun…
Corteva’s global reputation makes its products prime targets for counterfeiting organizations.
A counterfeit product is one that has been deliberately and fraudulently mislabeled as to its identity and source.
Corteva’s business may be adversely affected by the availability of counterfeit products.
Legislation and jurisprudence on patent protection is evolving and changes in laws could affect Corteva’s ability to obtain or maintain patent protection for, and otherwise enforce Corteva’s patents related to, its pr…
In addition, because of the rapid pace of technological change, the confidentiality of patent applications in some jurisdictions and/or the uncertainty in predicting the outcome of complex proceedings relating to owne…
Corteva has designed and implemented internal controls to restrict use of, access to and distribution of its intellectual property.
Corteva SEC Filings
Latest annual and quarterly reports, current reports, proxy statements and ownership filings.
| Form | Filed | Description | Document |
|---|---|---|---|
| Ownership change (13D/13G) amendment | 2026-11-05 | Large shareholder report (5% or more) | View document |
| Ownership change (13D/13G) amendment | 2026-11-04 | Large shareholder report (5% or more) | View document |
| Current report (8-K) | 2026-10-13 | Other news | View document |
| Current report (8-K) | 2026-10-07 | Executive change | View document |
| Current report (8-K) | 2026-10-07 | Change in shareholder rights, Other news | View document |
Corteva financial metrics by year
Compare Corteva with similar companies
- CTVA vs VYLR Vylor